Long-Term Patient-Reported Health-Related Quality of Life in the Randomized FORMULA-509 Trial of Salvage Radiotherapy and 6 Months of GnRH Agonist with Either Bicalutamide or Abiraterone Acetate Plus Prednisone and Apalutamide after Radical Prostatectomy

Autor: Hoffman, K.E., Nguyen, P.L., Rathkopf, D., Zurita-Saavedra, A., Spratt, D.E., Dess, R.T., Liauw, S., Szmulewitz, R., Einstein, D.J., Bubley, G., Yu, J.B., An, Y., Wong, A.C., Feng, F.Y., Mckay, R.R., Rose, B.S., Lee, K.Y., Kibel, A., Taplin, M.E.A., Kollmeier, M.A.
Zdroj: In International Journal of Radiation Oncology, Biology, Physics 1 October 2024 120(2) Supplement:S54-S54
Databáze: ScienceDirect